Status:
COMPLETED
Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Athletic Pubalgia
Eligibility:
All Genders
18+ years
Brief Summary
Chronic athletic pubalgia is a frequent sport condition in which the effectiveness of medical treatment has not been proven. Intra-muscular injection of botulinum toxin A may have positive effects on ...
Detailed Description
The investigators included consecutive individuals with chronic athletic pubalgia for whom medical and/or surgical treatments have failed and who were treated with an intra-muscular injection of botul...
Eligibility Criteria
Inclusion
- chronic AP
- symptom duration ≥ 3 months
- consistent clinical and magnetic resonance imaging findings according to the clinician
- failure of medical and/or surgical treatments with persistent pain and inability to return to play
- treatment with an intra-muscular injection of botulinum toxin A injection
Exclusion
- age under 18 years
- ongoing pregnancy or breastfeeding
- treatments by anticoagulants
- muscular disorder (e.g. polymyositis, myopathy or other neuromuscular conditions)
- guardianship or curatorship
- individuals who had received botulinum toxin type A treatment for less than one year
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05430893
Start Date
June 1 2017
End Date
March 31 2021
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de rééducation fonctionnelle, réadaptation de l'appareil locomoteur et Pathologies du Rachis - Cochin Hospital
Paris, Île-de-France Region, France, 75014